OncoCyte Corporation (OCX)
NASDAQ: OCX
· Real-Time Price · USD
3.20
0.47 (17.22%)
At close: Jun 17, 2025, 3:59 PM
OncoCyte Revenue
OncoCyte reported an annual revenue of $1.88M, reflecting a 25.15% growth. For the quarter ending March 31, 2025, OncoCyte generated $2.14M in revenue.
Revenue (ttm)
1.88M
Revenue Growth
25.15%
Price / Sales Ratio
16.54
Revenue / Employee
40.89K
Employees
46
Market Cap
91.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 1.88M | +25.15% |
| Dec 31, 2023 | 1.5M | +56.89% |
| Dec 31, 2022 | 958K | -87.60% |
| Dec 31, 2021 | 7.73M | +535.44% |
| Dec 31, 2020 | 1.22M | +Infinity% |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |